RID MOUSSE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rid Mousse, and when can generic versions of Rid Mousse launch?
Rid Mousse is a drug marketed by Bayer Healthcare Llc and is included in one NDA.
The generic ingredient in RID MOUSSE is piperonyl butoxide; pyrethrins. There is one drug master file entry for this compound. Additional details are available on the piperonyl butoxide; pyrethrins profile page.
Summary for RID MOUSSE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 6 |
Formulation / Manufacturing: | see details |
DailyMed Link: | RID MOUSSE at DailyMed |
Recent Clinical Trials for RID MOUSSE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Liverpool University Hospitals NHS Foundation Trust | Phase 4 |
Centre de Recherche du Centre Hospitalier de l'Université de Montréal | Phase 1 |
Cairo University | Phase 4 |
US Patents and Regulatory Information for RID MOUSSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer Healthcare Llc | RID MOUSSE | piperonyl butoxide; pyrethrins | AEROSOL;TOPICAL | 021043-001 | Mar 7, 2000 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |